Jennifer GoriVP, Research at Prime Medicine
Dr. Jennifer Gori is Vice President, Research, at Prime Medicine. Dr. Gori has 20 years of drug discovery experience, with roles spanning early phase drug discovery research in genome editing and gene and cell therapy to strategic planning and operations for clinical development. Prior to joining Prime Medicine, Dr. Gori led strategic planning and operations and in vivo pharmacology at Obsidian Therapeutics. Prior to Obsidian, Dr. Gori was an early scientist Editas Medicine where she led the preclinical scientific team to discover gene edited cell therapies for clinical development in Hematologic Disease indications. Dr. Gori holds a Ph.D. in Microbiology, Immunology and Cancer Biology from the University of Minnesota.